% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • llabtechtwo llabtechtwo Sep 22, 2012 12:20 PM Flag

    Kyprolis REV???

    We have had a pretty decent run on no news.... My two thoughts are someone in the "know" believes a buyout is imminent or someone thinks onxx will surprise to the upside on next earnings. I personally don't think the latter will materialize, so that leaves me thinking a buyout is in the works!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • We have indication of potential good sales from kyprolis. And impending regorafenib approval by end of Oct. With present nexavar and good kyprolis sales alone, 90$ target is reasonable. With regorafenib approval news pending by end of Oct and 5 phase 3 trials due to report results by end of year, there is high chance additional good news results...and finally we have potential buyout...the risk/reward for hedge funds, other institutional favors buying...I am now looking for 100+ before end of year.

      Sentiment: Strong Buy